Rampur Distillery Lights Up Diwali in Times Square New York City
Rampur Distillery celebrates Diwali 2024 with a striking display at Times Square, New York City.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030298390/en/
This #Diwali, we lit up Times Square with Rampur Indian Single Malt Asava - Best World Whisky! (Photo: Business Wire)
"Happy Diwali from all of us at Rampur Distillery! This festival symbolizes light, unity, and new beginnings. As we celebrate, we're proud to showcase our award-winning Rampur Indian Single Malt Whisky and introduce our Jugalbandi collection series, featuring Jugalbandi #5 and #6 expressions, set to launch in the United States in 2025. Times Square reflects our rich heritage and commitment to expanding our global presence. Together, let’s embrace the spirit of Diwali and look forward to a prosperous year ahead!" - Mr. Sanjeev Banga, President of International Business at Radico Khaitan.
In 2016, Rampur Distillery made a significant entry into the global whisky market with the launch of its flagship Rampur Select Indian Single Malt Whisky, quickly garnering attention for its rich flavor profile and exceptional craftsmanship.
As Diwali 2024 approaches, the distillery proudly celebrates its award-winning Rampur Asava, honored as the Best World Whisky 2023 by the John Barleycorn Awards. This accolade is a testament to Rampur's commitment to innovation and excellence in whisky-making.
Rampur Distillery has also expanded its luxury portfolio, offering a range of premium expressions crafted with meticulous attention to detail. Each expression showcases unique flavor profiles that reflect the artistry of Indian whisky-making. With the latest addition, Rampur Barrel Blush, the distillery continues to blend traditional techniques with modern influences, appealing to whisky enthusiasts and connoisseurs worldwide.
Mr. Kunal Madan, Vice President of International Business at Radico Khaitan, shares, “Happy Diwali! We are thrilled to celebrate this festive season with everyone. Alongside our award-winning products, we’re excited to share the news that we have recently launched Rampur Barrel Blush, our new expression that embodies the spirit of Diwali through its celebration of new beginnings and rich heritage. Just as Diwali signifies renewal and joy, this whisky invites you to share special moments with loved ones. Its intricate flavors complement the warmth of the season, making it a lovely choice to toast to prosperity and cherished memories. Cheers to family, festivities, and the joy of togetherness!”
Rampur Whisky offerings include:
- Rampur Select
- Rampur Double Cask
- Rampur Asava
- Rampur Barrel Blush
- Rampur Jugalbandi Series
- Sangam World Malt
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030298390/en/
Contacts
exports@radico.co.in
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CORRECTING and REPLACING PHOTO Decode the Future of AI and Customer Experience at Elevate'25 Digital Innovation Summit18.9.2025 21:23:00 EEST | Press release
Please replace the photo with the accompanying corrected photo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918928987/en/ Gain insight and advice from firms at the frontier of AI-powered, mobile-first customer experiences. The release reads: DECODE THE FUTURE OF AI AND CUSTOMER EXPERIENCE AT ELEVATE'25 DIGITAL INNOVATION SUMMIT With keynotes from Google Cloud and an independent research firm, Elevate’25 will provide actionable strategies to harness the power of AI and create exceptional experiences for today's mobile-first consumer As unprecedented advancements in AI reshape consumer behavior, digital innovation summit Elevate'25 opened for general registration today. Sponsored by Airship, the exclusive, one-day event is designed to equip business leaders with proven strategies to harness artificial intelligence and mobile-first technology for a decisive competitive advantage. Taking place on October 15, 2025, at the i
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, India18.9.2025 19:22:00 EEST | Press release
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient (API) production, in Bidar, India. Located alongside Unit IV, the company’s flagship API manufacturing site, Unit VI has been established exclusively for veterinary APIs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918612071/en/ Sai Life Sciences’ Veterinary APIs Unit in Bidar, India. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, Sai Life Sciences aims to provide efficient and scalable manufacturing solutions to leading global animal health companies. Making the announcement, Krishna Kanumuri, CEO & Managing Direct
Celltrion Announces Commercial Availability of Omlyclo™ Across Europe at EADV 202518.9.2025 18:45:00 EEST | Press release
Celltrion, Inc. today showcased its longstanding commitment to expanding its biosimilar portfolio in the field of immuno-dermatology by attending the 2025 European Academy of Dermatology and Venereology (EADV) Congress, held 17-20 September in Paris, France. Following the European Commission (EC) approval of Omlyclo™, the first and only omalizumab biosimilar in Europe in May 2024, Omlyclo™ will be commercially available starting in Norway, with subsequent rollouts in European countries. As part of Celltrion’s mission to advance knowledge and understanding in dermatology, especially in chronic spontaneous urticaria (CSU), the company hosted satellite symposium presenting the results of the global Phase III clinical trial of Omlyclo™. The global Phase III clinical trial involved 619 patients with CSU, following them up to week 40. Patients were randomized to receive 300 mg or 150 mg of Omlyclo™, or reference product, every 4 weeks. Starting from week 12, patients who received Omlyclo™ we
Setting the Standard: AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’18.9.2025 17:40:00 EEST | Press release
AMRA Medical is proud to share its inclusion in the World’s Top HealthTech Companies list, published today by TIME in collaboration with Statista. This recognition positions AMRA among an elite group of global innovators that are leading healthcare transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250918372780/en/ AMRA Medical Recognized as one of TIME Magazine’s ‘World’s Top HealthTech Companies’ The selection, which comes just one week after celebrating AMRA’s 15 years of progress and innovation within the body composition space, highlights AMRA’s long-standing commitment to becoming a global leader in health informatics. By delivering detailed, reproducible insights within fat distribution and muscle composition, AMRA’s MRI-based technology is helping clinicians, researchers, and healthcare organizations unlock new levels of understanding across the metabolic and musculoskeletal sectors. “Being recognized by
illumynt, a CNE Direct Company, Is Pleased to Announce the Promotion of Jörg Herbarth to Chief Executive Officer (CEO)18.9.2025 17:30:00 EEST | Press release
illumynt, a CNE Direct company, is pleased to announce the promotion of Jörg Herbarth to Chief Executive Officer (CEO). Jörg has been a key member of illumynt’s executive leadership team since joining in June 2022, most recently serving as Chief Operating Officer. In his new role as CEO, Jörg will spearhead illumynt’s mission to become the number one provider of AI- and data-centric IT Asset Disposition (ITAD) solutions worldwide. Paul Knight, illumynt’s current CEO, will transition to the role of Founder & Chairman. In this capacity, Paul will continue to support the executive team with strategic guidance, while Jörg assumes full leadership of day-to-day operations and global expansion initiatives. Mr. Knight had come out of retirement a year ago to undertake some new initiatives and advance the company's strategic direction. With some necessary changes having taken place- he is thrilled to facilitate this transition to a reduced role again. Under Jörg’s leadership, illumynt will cont
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom